Context determines the type of sensitized behaviour: A brief review and a hypothesis on the role of environment in behavioural sensitization

Behavioural Pharmacology

Volumn 11, Issue 3-4, 2000, Pages 211-221

  Ohmori, T ^a   Abekawa, T ^b   Ito, K ^b   Koyama, T ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Behavioural sensitization; Conditioning; Environment; Psychostimulant

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMPHETAMINE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PSYCHOSTIMULANT AGENT; QUINPIROLE; SEROTONIN;

ASSOCIATIVE MEMORY; BEHAVIOR MODIFICATION; CONDITIONED REFLEX; CONDITIONING; DRUG EFFECT; ENVIRONMENT; LICKING; LOCOMOTION; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; REARING; REVIEW; SENSITIZATION; SNIFFING;

EID: 0033936602     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200006000-00005     Document Type: Review

References (95)

1. Akimoto K, Hamamura T, Otsuki S (1989). Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studies by in vivo intracerebral dialysis. Brain Res 490:339-344.
2. Anagnostaras SG, Robinson TE (1996). Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behav Neurosci 110:1397-1414.
3. Ahmed SH, Stinus L, Le Moal M, Cador M (1993). Controlling interindividual differences in the unconditioned response to amphetamine in the study of environment-dependent sensitization. Behav Pharmacol 4:355-365.
4. Ahmed SH, Cador M, Le Moal M, Stinus L (1995). Amphetamine-induced conditioned activity in rats: comparison with novelty-induced activity and role of the basolateral amygdala. Behav Neurosci 4:723-733.
5. Ahmed SH, Oberling P, Di Scala G, Sandner G (1996). Amphetamine-induced conditioned activity does not result from a failure of rats to habituate to novelty. Psychopharmacology 123:325-332.
6. Badiani A, Anagnostaras SG, Robinson TE (1995a). The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment. Psychopharmacology 117:443-452.
7. Badiani A, Browman KE, Robinson TE (1995b). Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674:291-298.
8. Badiani A, Camp DM, Robinson TE (1997). Enduring enhancement of amphetamine sensitization by drug-associated environmental stimuli. J Pharmacol Exp Ther 282:787-794.
9. Barr GA, Sharpless NS, Cooper S, Schiff SR, Paredes W, Bridger WH (1983). Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy. Life Sci 33:1341-1351.
10. Beck CHM, Chow HL, Cooper SJ (1986). Initial environment influences amphetamine-induced stereotypy: subsequently environment change has little effect. Behav Neural Biol 46:383-397.
11. Beninger RJ, Hahn BL (1983). Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220:1394-1306.
12. Browman KE, Badiani A, Robinson TE (1997). Dose-dependent environmental influences on the induction of sensitization following i.v. amphetamine. Abstr Soc Neurosci 23:2404.
13. Brown EE, Fibiger HC (1992). Cocaine-induced conditioned locomotion: absence of associated increases in dopamine release. Neuroscience 48:621-629.
14. Browne RC, Segal DS (1977). Metabolic and experimental factors in the behavioral response to repeated amphetamine. Pharmacol Biochem Behav 6:545-552.
15. Carey RT (1986). Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra. Brain Res 365:379-382.
16. Carlezon WA, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ (1997). Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814.
17. Carlin AS, Bakker CB, Halpern L, Post RD (1972). Social facilitation of marijuana intoxication: impact of social set and pharmacological activity. J Abnorm Psychol 80:132-140.
18. Castaneda E, Becker JB, Robinson TE (1988). The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KC1 and electrical stimulation evoked striatal dopamine release in vitro. Life Sci 42:2447-2456.
19. Chait LD (1993). Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav Pharmacol 4:191-199.
20. Collingridge GL, Bliss TVP (1987). NMDA receptors - their role in long-term potentiation. Trends Neurosci 10:288-293.
21. Crombag HS, Badiani A, Robinson TE (1996). Signalled versus unsignalled intravenous amphetamine: large difference in the acute psychomotor response and sensitization. Brain Res 722:227-231.
22. Damianopoulos EN, Carey RJ (1992). Conditioning, habituation and behavioral reorganization factors in chronic cocaine effects. Behav Brain Res 49:149-157.
23. Dietze S, Kuschinsky K (1994). Effect of conditioning with d-amphetamine on the extracellular concentration of dopamine and its metabolites in the striatum of behaving rats. Naunyn-Schmiedeberg's Arch Pharmacol 350:22-27.
24. Dingledine R, McBain CJ, McNamara JO (1990). Excitatory amino acid receptors in epilepsy. Trends Pharmacol Sci 11:334-338.
25. Drew KL, Glick SD (1987). Classical conditioning of amphetamine-induced lateralized and nonlateralized activity in rats. Psychopharmacology 92:52-57.
26. Drew KL, Glick SD (1988a). Environment-dependent sensitization to amphetamine-induced circling behavior. Pharmacol Biochem Behav 31:705-708.
27. Drew KL, Glick SD (1988b). Characterization of the associative nature of sensitization to amphetamine-induced circling behavior and the environment dependent placebo-like response. Psychopharmacology 95:482-487.
28. Drew KL, Glick SD (1990). Role of D-1 and D-2 receptor stimulation to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response. Psychopharmacology 101:465-471.
29. Einat H, Szechtman H (1993). Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole. Behav Pharmacol 4:399-403.
30. Einat H, Einat D, Allan M, Talangbayan H, Tsafnat T, Szechtman H (1996). Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology 127:95-101.
31. Ellinwood EH (1971). Accidental conditioning with chronic methamphetamine intoxication: implications for a theory of drug habituation. Psychopharmacology 21:131-138.
32. Ellinwood EH, Escalante OD (1970). Behavior and histopathological findings during chronic methedrine intoxication. Biol Psychiatry 2:27-39.
33. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996). Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
34. Fontana DJ, Post RM, Pert A (1993). Conditioned increase in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res 629:31-39.
35. Gold LH, Swerdlow NR, Koob GF (1988). The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine. Behav Neurosci 102:544-552.
36. Hayashi T, Ohashi K, Tadokoro S (1980). Conditioned drug effects to d-amphetamine-and morphine-induced motor acceleration in mice: experimental approach for placebo effect. Jpn J Pharmacol 30:93-100.
37. Hayashi T, Kuribara M, Tadokoro S (1987). Enhancement of ambulation-increasing effect produced by repeated administration of methamphetamine in rats and neurochemical change in catecholaminergic neurons. Jpn J Pharmacol 43:283-290.
38. Heidbreder CA, Shippenberg TS (1996). Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine. Synapse 24:182-192.
39. Hinson RE, Poulos CX (1981). Sensitization to the behavioral effects of cocaine: modification by Pavlovian conditioning. Pharmacol Biochem Behav 15:559-562.
40. Hirabayashi M, Alam MR (1981). Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol Biochem Behav 15:925-932.
41. Hiroi N, White NM (1989). Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change. Pharmacol Biochem Behav 32:249-258.
42. Hoffman DC, Wise RA (1992). Locomotor-activating effects of the D2 agonist bromocriptine show environment-specific sensitization following repeated injections. Psychopharmacology 107:277-284.
43. Ito K, Ohmori T, Abekawa T, Koyama T (1997). Clonazepam blocks behavioral sensitization to methamphetamine. Pharmacol Biochem Behav 58:875-879.
44. Kalivas PW, Duffy P (1990). The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58.
45. Kalivas PW, Duffy P (1993). Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
46. Kalivas PW, Stewart J (1991). Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
47. Kalivas PW, Weber B (1988). Amphetamine injection into the central mesencephalon sensitized rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095-1102.
48. Kalivas PW, Sorg BA, Hooks MS (1993). The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
49. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989). Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
50. Karler R, Calder LD, Turkanis SA (1991). DNQX blockade of amphetamine behavioral sensitization. Brain Res 552:295-300.
51. Kazahaya Y, Akimoto K, Otsuki S (1989). Subchronic methamphetamine treatment enhances methamphetamine-or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903-912.
52. Lienau AK, Kuschinsky K (1997). Sensitization phenomena after repeated administration of cocaine or d-amphetamine in rats: associative and non-associative mechanisms and the role of dopamine in the striatum. Naunyn-Schmiedeberg's Arch Pharmacol 355:531-537.
53. Martin-Iverson MT, Fawcett SL (1996). Pavlovian conditioning of psychomotor stimulant-induced behaviors: has convenience led us astray? Behav Pharmacol 7:24-41.
54. Mattingly BA, Gotsick JE (1989). Conditioning and experimental factors affecting the development of sensitization to apomorphine. Behav Neurosci 103:1311-1317.
55. Mattingly BA, Rowlett JK, Graff JT, Hatton BJ (1991). Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine. Psychopharmacology 105:501-507.
56. Mattingly BA, Hart TC, Lim K, Perkins C (1994). Selective antagonism of dopamine D1 and D2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology 114:239-242.
57. Mattingly BA, Koch C, Osborne FH, Gotsick JE (1997). Stimulus and response factors affecting the development of behavioral sensitization to apomorphine. Psychopharmacology 130:109-116.
58. Mazurski E, Beninger RJ (1987). Environment specific conditioning and sensitization with (+)-amphetamine. Pharmacol Biochem Behav 27:61-65.
59. Moeller HG, Nowak K, Kuschinsky K (1987). Conditioning of pre-and post-synaptic behavioral responses to the dopamine receptor agonist apomorphine in rats. Psychopharmacology 91:50-55.
60. Mumford M, Teixeira AR, Kumar A (1979). Sources of variation in locomotor activity and stereotypy in rats treated with d-amphetamine. Psychopharmacology 62:241-245.
61. Ohmori T, Abekawa T, Koyama T (1994). Competitive and non-competitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48:587-591.
62. Ohmori T, Abekawa T, Koyama T (1995a). Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment. Psychopharmacology 121:158-163.
63. Ohmori T, Abekawa T, Koyama T (1995b). Environment modifies the expression of behavioral sensitization produced by methamphetamine: behavioral and neurochemical studies. Behav Pharmacol 6:133-142.
64. Pavlov LP (1927). Conditioned Reflexes. London: Oxford University Press.
65. Pettit HO, Pan H-T, Parsons LH, Justice JB Jr (1990). Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804.
66. Pickens RW, Crowder WF (1967). Effects of CS-US interval on conditioning of drug response with assessment of speed of conditioning. Psychopharmacologia 11:88-94.
67. Pierce RC, Kalivas PW (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
68. Pope SG, Dean P, Redgrave P (1980). Dissociation of d-amphetamine-induced locomotor activity and stereotyped behavior by lesions of the superior colliculus. Psychopharmacology 70:297-302.
69. Post RM (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149:999-1010.
70. Post RM, Weiss SRB (1998). Sensitization and kindling phenomena in mood, anxiety and obsessive-compulsive disorders: the role of serotonergic mechanism in illness progression. Biol Psychiatry 44:193-206.
71. Post RM, Lockfeld A, Squillace KM, Contel NR (1981). Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 28:755-760.
72. Robinson TE (1984). Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology 84:466-475.
73. Robinson TE, Becker JB (1982). Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 85:253-254.
74. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198.
75. Robinson TE, Jurson PA, Bennet JA, Bentgen KM (1988). Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211-222.
76. Schiff SR (1982). Conditioned dopaminergic activity. Biol Psychiatry 17:135-154.
77. Segal DS (1975). Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv Biochem Psychopharmacol 13:247-262.
78. Segal DS, Kuczenski R (1992a). In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 571:330-337.
79. Segal DS, Kuczenski R (1992b). Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 577:351-355.
80. Stewart J, Vezina P (1991). Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine. Behav Pharmacol 2:65-71.
81. Sullivan R, Dogaru C, Szechtman H (1992). Constriction of environmental space and behavioral response to the dopamine agonist quinpirole. Pharmacol Biochem Behav 43:1217-1219.
82. Szechtman H, Eilam D, Teitelbaum P, Golani I (1988). A different look at measurement and interpretation of drug-induced stereotyped behavior. Psychobiology 16:164-173.
83. Szechtman H, Talangbayan H, Eilam D (1993). Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behav Pharmacol 4:405-410.
84. Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D (1994). Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology 115:95-104.
85. Szumlinski KK, Allan M, Talangbayan H, Tracey A, Szechtman H (1997). Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology 134:193-200.
86. Tilson HA, Rech RH (1973). Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity. Pharmacol Biochem Behav 1:149-153.
87. Vezina P, Stewart J (1989). The effect of dopamine receptor blockade on the development of sensitization to the motor activating effects of amphetamine and morphine. Brain Res 449:108-120.
88. Vezina P, Stewart J (1990). Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: luck of conditioned effects. Brain Res 516:99-106.
89. Weiss F, Paulus MP, Lorang MT, Koob GF (1992). Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 12:4372-4380.
90. Willner P, Papp M, Cheeta S, Muscat R (1992). Environmental influences on behavioral sensitization to the dopamine agonist quinpirole. Behav Pharmacol 3:43-50.
91. Wolf ME, Khansa MR (1991). Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
92. Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR (1993). Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J Pharmacol Exp Ther 264:249-255.
93. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.
94. Yamada S, Kojima H, Yokoo H, Tsutsumi K, Takamuki S, Anraku S, Nishi S, Inanaga K (1988). Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine. Biol Psychiatry 24:399-408.
95. Zhou LW, Qin ZN, Weiss B (1991). Down-regulation of stereo-typed behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. Neuropsychopharmacology 4:47-55.